vs
Side-by-side financial comparison of MOVADO GROUP INC (MOV) and Stoke Therapeutics, Inc. (STOK). Click either name above to swap in a different company.
MOVADO GROUP INC is the larger business by last-quarter revenue ($186.1M vs $158.6M, roughly 1.2× Stoke Therapeutics, Inc.). Stoke Therapeutics, Inc. runs the higher net margin — 71.2% vs 5.1%, a 66.0% gap on every dollar of revenue. On growth, Stoke Therapeutics, Inc. posted the faster year-over-year revenue change (3661.1% vs 1.9%). Stoke Therapeutics, Inc. produced more free cash flow last quarter ($131.7M vs $11.6M).
Movado is a luxury American watch brand originally founded in 1881 in Switzerland. Movado means "movement" in Esperanto. The watches are known for their signature metallic dot at 12 o'clock and minimalist style; the company is best known for its Museum Watch.
Stoke Therapeutics, Inc. is a clinical-stage biotechnology company developing innovative RNA-targeted therapies for severe rare genetic diseases. Its lead candidates address unmet needs for Dravet syndrome, a rare epilepsy, and other neurological monogenic disorders, serving patients across North America and global markets.
MOV vs STOK — Head-to-Head
Income Statement — Q3 FY2026 vs Q1 FY2025
| Metric | | |
|---|---|---|
| Revenue | $186.1M | $158.6M |
| Net Profit | $9.6M | $112.9M |
| Gross Margin | 54.3% | — |
| Operating Margin | 6.3% | 70.2% |
| Net Margin | 5.1% | 71.2% |
| Revenue YoY | 1.9% | 3661.1% |
| Net Profit YoY | 89.8% | 528.0% |
| EPS (diluted) | $0.42 | $1.90 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $186.1M | — | ||
| Q3 25 | $161.8M | — | ||
| Q2 25 | $131.8M | — | ||
| Q1 25 | $181.5M | $158.6M | ||
| Q4 24 | $180.5M | $22.6M | ||
| Q3 24 | $157.0M | — | ||
| Q2 24 | $134.4M | — | ||
| Q1 24 | $175.8M | — |
| Q4 25 | $9.6M | — | ||
| Q3 25 | $3.0M | — | ||
| Q2 25 | $1.4M | — | ||
| Q1 25 | $8.1M | $112.9M | ||
| Q4 24 | $4.8M | $-10.5M | ||
| Q3 24 | $3.5M | — | ||
| Q2 24 | $2.0M | — | ||
| Q1 24 | $9.8M | — |
| Q4 25 | 54.3% | — | ||
| Q3 25 | 54.1% | — | ||
| Q2 25 | 54.1% | — | ||
| Q1 25 | 54.2% | — | ||
| Q4 24 | 53.5% | — | ||
| Q3 24 | 54.3% | — | ||
| Q2 24 | 54.3% | — | ||
| Q1 24 | 53.5% | — |
| Q4 25 | 6.3% | — | ||
| Q3 25 | 2.5% | — | ||
| Q2 25 | 0.2% | — | ||
| Q1 25 | 5.1% | 70.2% | ||
| Q4 24 | 3.3% | -60.4% | ||
| Q3 24 | 1.7% | — | ||
| Q2 24 | 1.6% | — | ||
| Q1 24 | 6.1% | — |
| Q4 25 | 5.1% | — | ||
| Q3 25 | 1.8% | — | ||
| Q2 25 | 1.1% | — | ||
| Q1 25 | 4.4% | 71.2% | ||
| Q4 24 | 2.7% | -46.4% | ||
| Q3 24 | 2.2% | — | ||
| Q2 24 | 1.5% | — | ||
| Q1 24 | 5.6% | — |
| Q4 25 | $0.42 | — | ||
| Q3 25 | $0.13 | — | ||
| Q2 25 | $0.06 | — | ||
| Q1 25 | $0.36 | $1.90 | ||
| Q4 24 | $0.21 | $-0.15 | ||
| Q3 24 | $0.15 | — | ||
| Q2 24 | $0.09 | — | ||
| Q1 24 | $0.44 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $183.9M | $274.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $497.5M | $350.1M |
| Total Assets | $751.9M | $406.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $183.9M | — | ||
| Q3 25 | $180.5M | — | ||
| Q2 25 | $203.1M | — | ||
| Q1 25 | $208.5M | $274.8M | ||
| Q4 24 | $181.5M | $128.0M | ||
| Q3 24 | $198.3M | — | ||
| Q2 24 | $225.4M | — | ||
| Q1 24 | $262.1M | — |
| Q4 25 | $497.5M | — | ||
| Q3 25 | $489.9M | — | ||
| Q2 25 | $493.2M | — | ||
| Q1 25 | $481.3M | $350.1M | ||
| Q4 24 | $491.3M | $229.0M | ||
| Q3 24 | $492.0M | — | ||
| Q2 24 | $489.6M | — | ||
| Q1 24 | $505.9M | — |
| Q4 25 | $751.9M | — | ||
| Q3 25 | $748.7M | — | ||
| Q2 25 | $747.2M | — | ||
| Q1 25 | $729.2M | $406.9M | ||
| Q4 24 | $747.2M | $271.6M | ||
| Q3 24 | $742.5M | — | ||
| Q2 24 | $736.0M | — | ||
| Q1 24 | $756.5M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $12.3M | $131.8M |
| Free Cash FlowOCF − Capex | $11.6M | $131.7M |
| FCF MarginFCF / Revenue | 6.2% | 83.0% |
| Capex IntensityCapex / Revenue | 0.4% | 0.1% |
| Cash ConversionOCF / Net Profit | 1.28× | 1.17× |
| TTM Free Cash FlowTrailing 4 quarters | $35.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $12.3M | — | ||
| Q3 25 | $-3.8M | — | ||
| Q2 25 | $-7.2M | — | ||
| Q1 25 | $39.1M | $131.8M | ||
| Q4 24 | $-4.7M | $-23.2M | ||
| Q3 24 | $-17.8M | — | ||
| Q2 24 | $-18.1M | — | ||
| Q1 24 | $69.4M | — |
| Q4 25 | $11.6M | — | ||
| Q3 25 | $-5.1M | — | ||
| Q2 25 | $-8.7M | — | ||
| Q1 25 | $37.5M | $131.7M | ||
| Q4 24 | $-7.2M | $-23.2M | ||
| Q3 24 | $-20.1M | — | ||
| Q2 24 | $-19.7M | — | ||
| Q1 24 | $67.8M | — |
| Q4 25 | 6.2% | — | ||
| Q3 25 | -3.1% | — | ||
| Q2 25 | -6.6% | — | ||
| Q1 25 | 20.7% | 83.0% | ||
| Q4 24 | -4.0% | -102.7% | ||
| Q3 24 | -12.8% | — | ||
| Q2 24 | -14.7% | — | ||
| Q1 24 | 38.6% | — |
| Q4 25 | 0.4% | — | ||
| Q3 25 | 0.8% | — | ||
| Q2 25 | 1.2% | — | ||
| Q1 25 | 0.9% | 0.1% | ||
| Q4 24 | 1.4% | 0.2% | ||
| Q3 24 | 1.5% | — | ||
| Q2 24 | 1.2% | — | ||
| Q1 24 | 0.9% | — |
| Q4 25 | 1.28× | — | ||
| Q3 25 | -1.27× | — | ||
| Q2 25 | -5.08× | — | ||
| Q1 25 | 4.86× | 1.17× | ||
| Q4 24 | -0.98× | — | ||
| Q3 24 | -5.14× | — | ||
| Q2 24 | -8.97× | — | ||
| Q1 24 | 7.06× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MOV
| Other | $81.4M | 44% |
| Owned Brands Category | $46.0M | 25% |
| Sales Channel Directly To Consumer | $35.3M | 19% |
| Company Stores | $23.4M | 13% |
STOK
Segment breakdown not available.
